When people think about inflammatory bowel disease, they usually think about digestive symptoms such as stomach pain and diarrhea.
However, a new study suggests the condition may also affect mental health long before doctors recognize the disease. The research was published in Clinical Gastroenterology and Hepatology.
IBD is a lifelong illness in which the immune system causes ongoing inflammation in the digestive tract. Crohn’s disease and ulcerative colitis are the two most common forms. Although treatments can control symptoms, many patients experience repeated flare-ups that affect daily life.
Researchers in Sweden analysed nationwide health records covering more than 40,000 people with IBD. They compared these patients with almost 180,000 people without IBD as well as more than 26,000 unaffected full siblings. This design helped separate the effects of IBD from family-related influences.
The study revealed that psychiatric disorders became more common two to three years before IBD was diagnosed. The risk increased sharply around the time of diagnosis and remained above normal for at least a decade.
Depression, anxiety and substance misuse accounted for most of the increase. The researchers also noticed that prescriptions for antidepressant and anti-anxiety medicines started rising about a year before IBD diagnosis, suggesting that emotional symptoms often appear before bowel disease is formally identified.
The pattern was similar regardless of whether patients had Crohn’s disease or ulcerative colitis. Children who developed IBD and people with a family history of psychiatric illness faced the greatest absolute risks.
There are several possible explanations for these findings. Chronic inflammation may influence brain function, while physical symptoms, uncertainty, social limitations and lower quality of life may all contribute to emotional distress. Scientists also believe communication between the gut and the brain may play an important role.
The researchers believe healthcare providers should begin screening for mental health symptoms as soon as patients are being evaluated for possible IBD rather than waiting until after diagnosis. Early treatment of depression and anxiety could improve quality of life and may even help people manage their bowel disease more successfully.
Although the study found a strong association, it cannot prove that IBD directly causes psychiatric disorders. Other biological and environmental factors may also contribute, and additional research is needed to understand the underlying mechanisms.
The use of nationwide databases and sibling comparisons makes this one of the strongest observational studies on mental health and IBD to date. Nevertheless, it relies on medical records, which may miss milder psychiatric symptoms. The findings provide strong support for combining psychological care with routine treatment for people at risk of or living with IBD.
Source: Clinical Gastroenterology and Hepatology.
